Rare expression of high-molecular-weight cytokeratin in adenocarcinoma of the prostate gland: a study of 100 cases of metastatic and locally advanced prostate cancer.
about
Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinomaNormal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factorExpression of basal cell keratins in human prostate cancer metastases and cell lines.The epithelium-specific ETS protein EHF/ESE-3 is a context-dependent transcriptional repressor downstream of MAPK signaling cascades.High-grade prostatic intraepithelial neoplasia.Stem cell differentiation within the human prostate epithelium: implications for prostate carcinogenesis.Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies.Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature.Urothelial-type adenocarcinoma of the prostate mimicking metastatic colorectal adenocarcinoma.Functions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies.The expression of cytokeratin 19 in lymph nodes was a poor prognostic factor for hepatocellular carcinoma after hepatic resectionHigh-grade prostatic intraepithelial neoplasia of the prostate: the precursor lesion of prostate cancer.Differences in the structural features of atypical adenomatous hyperplasia and low-grade prostatic adenocarcinoma.Precursors of prostate cancer.Screening and identification of the tumor-associated antigen CK10, a novel potential liver cancer marker.Study of immunohistochemistry in prostatic lesions with special reference to proliferation and invasivenessDiagnostic utility of α-methylacyl CoA racemase (P504S) & HMWCK in morphologically difficult prostate cancer.Molecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues.p63 is more sensitive and specific than 34βE12 to differentiate adenocarcinoma of prostate from cancer mimickers.Different Growth Patterns of Canine Prostatic Carcinoma Suggests Different Models of Tumor-Initiating Cells.Retained basal cells in metastatic prostate cancer.Demonstration of intermediate cells during human prostate epithelial differentiation in situ and in vitro using triple-staining confocal scanning microscopy.Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.Human epithelial basal cells are cells of origin of prostate cancer, independent of CD133 status.Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.Typing the atypical: Diagnostic issues and predictive markers in suspicious prostate lesions.A comparison of basal cell markers used in the prostate.High molecular weight cytokeratin antibody (clone 34betaE12): a sensitive marker for differentiation of high-grade invasive urothelial carcinoma from prostate cancer.
P2860
Q28139426-E3093512-A9F7-4AC1-B158-347B5CDB4592Q28345285-B1C89B1C-A2B3-45BE-9A6C-E8E2ABCDEC17Q32048563-FE873C20-EE9C-4550-BA2D-3323CFDEC05AQ33939002-AAB77CE6-5B9C-4E9A-A32E-2E86F5347084Q34291962-5AD8FDF4-B4F3-4627-9F30-9F28773A99D5Q34394076-F840D070-DFD6-4086-A165-67C6D4E42112Q35287094-20156B3C-03B6-4731-A09D-356296C25006Q36176427-F73B48E6-27EF-46EB-A302-1F73C98E288DQ36698671-98E31B3B-E466-473D-8105-49767D895077Q36860976-862239A2-B097-4997-B9D1-470B8EE22509Q37004173-B7A43E58-604E-4859-8368-88F9CE66A101Q37374251-219DA08D-0D3D-4556-8B46-A84C53F0583EQ37495468-8D5FCCBE-8D83-4929-BCA8-DB729FAFD867Q37972697-48D6C460-7204-4854-A846-23E1B4B0CBB3Q38704948-AACB97C5-0C19-4F48-9F72-EC64EC95B2A2Q42144819-E77AA7AF-BD28-4E1D-A62F-F3AE649375F9Q42155258-30E0BA84-D6E6-4C5B-AC4F-FD0A879C1694Q42184292-E38D9FED-B473-4B78-BF21-F382FF3C82D9Q42468989-219AAEE6-B4F9-499E-AEBA-7E05F88BFB72Q42473959-AABA008F-31F8-4CB8-BDAE-481459E930DEQ42487260-75B5107B-1E94-41C5-AF97-F3BAE696BFECQ42492179-EFBFBAEC-C5BE-465B-93D0-A6B127DB7DB5Q42504248-D84C0E1D-442D-4E48-9119-22DC130BA4E5Q42506512-5E972B6F-6992-4B7B-A48D-E11DE5789999Q42508375-8A625474-BD2E-43E7-AE67-55EDAFC588CAQ42513914-6DB9C285-EC16-4EFE-ADE9-D259D1C1C136Q42521360-1F8995B0-D301-4265-AD7C-985753DE219EQ47173367-D5A93880-5678-4974-81C6-74684A030D10
P2860
Rare expression of high-molecular-weight cytokeratin in adenocarcinoma of the prostate gland: a study of 100 cases of metastatic and locally advanced prostate cancer.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Rare expression of high-molecu ...... ally advanced prostate cancer.
@en
Rare expression of high-molecu ...... ally advanced prostate cancer.
@nl
type
label
Rare expression of high-molecu ...... ally advanced prostate cancer.
@en
Rare expression of high-molecu ...... ally advanced prostate cancer.
@nl
prefLabel
Rare expression of high-molecu ...... ally advanced prostate cancer.
@en
Rare expression of high-molecu ...... ally advanced prostate cancer.
@nl
P2093
P1476
Rare expression of high-molecu ...... ally advanced prostate cancer.
@en
P2093
P304
P356
10.1097/00000478-199902000-00002
P407
P577
1999-02-01T00:00:00Z